Response to: 'Correspondence on 'SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response'' by Westhoff et al.
Michael Markus BonelliDaniel AletahaPublished in: Annals of the rheumatic diseases (2021)